0000885590-13-000073.txt : 20130816 0000885590-13-000073.hdr.sgml : 20130816 20130816161048 ACCESSION NUMBER: 0000885590-13-000073 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130816 FILED AS OF DATE: 20130816 DATE AS OF CHANGE: 20130816 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schiller Howard Bradley CENTRAL INDEX KEY: 0001536053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 131045449 MAIL ADDRESS: STREET 1: 4787 CITY: MONTREAL STATE: A8 ZIP: H4R 2P9 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2013-08-16 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001536053 Schiller Howard Bradley 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 0 1 0 0 EVP and CFO Common Stock, no par values 2013-08-16 4 M 0 90000 0 A 279218 D Common Stock, no par values 2013-08-16 4 F 0 45230 0 D 233988 D Restricted Share Units 0 2013-08-16 4 M 0 90000 0 D Common Stock 90000 90000 D This represents a one-time payout of common shares issued upon the accelerated vesting of performance-based RSUs ("PSUs") that were previously reported. The initial grant was reported to vest based on total shareholder return (TSR) between a price of $42.70 starting on December 1, 2011 and the average stock price for the prior 20 trading days as of three measurement dates: 25% would vest on September 1, 2014, 50% on December 1, 2014 and 25% on March 1, 2014. Unit vesting is contingent on TSR performance between 15% and 45% into between one and three shares of common stock, respectively, with early vesting possible at higher TSR levels. Additional common shares pursuant to this award of PSUs may be earned upon the future achievement of TSR performance targets. This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1. This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units. by: Nicholas Zanoni for Howard Schiller 2013-08-16